Priming-Dependent Phosphorylation and Regulation of the Tumor Suppressor pVHL by Glycogen Synthase Kinase 3
2006 · Molecular and Cellular Biology · 82 citations
https://doi.org/10.1128/mcb.00232-06
C
Claudio R. Thoma
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
62
Papers
2.5K
Citations
21
h-index
24
i10-index
Claudio R. Thoma is an academic researcher from Novartis (United States). The author has contributed to research in topics: Microtubule and mitosis dynamics & Ubiquitin and proteasome pathways & Protein Degradation and Inhibitors. The author has an h-index of 21, co-authored 53 publications.
ORCID: 0000-0003-3475-0179Papers by this author
worksDCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance
2024 · Nature Communications · 76 citations
https://doi.org/10.1038/s41467-023-44237-4
Identification and Functional Characterization of pVHL-Dependent Cell Surface Proteins in Renal Cell Carcinoma
2012 · Neoplasia · 53 citations
https://doi.org/10.1596/neo.12130
Structure of the MRAS–SHOC2–PP1C phosphatase complex
2022 · Nature · 48 citations
https://doi.org/10.1038/s41586-022-05086-1
Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance
2024 · Nature Communications · 1 citations
https://doi.org/10.1038/s41467-024-51317-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat